How to import and distribute medicines in Ethiopia — EFDA importer licensing, the local agent requirement, import permits, and distribution rules

Establishing a foreign business in Ethiopia in 2026 — the investment permit, the capital-importation trap, the new forex regime, and the 2024 reforms.

Ethiopia's 2019 CSO Proclamation opened the door to a far more workable legal environment for civil society — but registration is only the beginning. This guide explains who must register, how the process works, and the ongoing obligations that most often catch organizations off guard.

Ethiopia has built an internationally recognized framework for clinical trial oversight — confirmed by WHO Maturity Level 3 status. For sponsors and investigators, the path runs through two gates: regulatory authorization by EFDA and independent ethical review. This guide explains the process, the timelines, the participant protections, and where applications stall.

Under Ethiopia's Personal Data Protection Proclamation, whenever you let another company handle personal data on your behalf, the law requires a written contract with specific terms. Most existing Ethiopian contracts don't have one — and the liability for the gap sits with the organization that owns the data.

No medicine may be sold in Ethiopia without marketing authorization from the EFDA— but not every product travels the same path. With Ethiopia now a WHO Maturity Level 3 regulator, faster routes exist for products already approved by stringent regulators. This guide walks through the pathways, the dossier, and where applications stall.

Ethiopia's Personal Data Protection Proclamation No. 1321/2024 has introduced significant new obligations for organizations handling personal data. Most are not yet compliant. Here is a practical guide and the three steps every organization should take now.